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 In vivo oxygen sensing is a critical area of research for medical applications, such as 
ischemic stroke, but this important topic is not fully understood or resolved. In addition, the best 
method for calibration of in vivo sensors is as yet undetermined. For all implantable devices, 
biofouling, the adsorption of biological material to the device surface, is another significant 
problem with no clear or well-defined solution. One method employed is to apply a protective 
polymer membrane to the sensor surface in order to minimize the adsorption of biological 
material. The work described here investigates two polymers applied to a gold electrode for 
oxygen sensing: polyeugenol (PE) and poly-o-phenylenediamine (PoPD). Polyeugenol, while 
permeable to oxygen, and unhampering to the overall oxygen sensitivity for the sensor, shows 
polymer instability, and is therefore not applicable to long-term in vivo sensors. PoPD is shown 
in these works to be both permeable to oxygen and mechanically stable. PoPD was investigated 
first on 2 mm gold macroelectrodes to increase the fundamental understanding of PoPD for use 
with oxygen sensors, as well as better understand the biofouling phenomenon when PoPD-coated 
electrodes were incubated in protein solutions. In addition, PoPD-coated 2 mm gold electrodes 
were used in an in vivo simulation study in order to illustrate the problem with present 
calibration methods for in vivo sensors. PoPD was further investigated using gold 
microelectrodes in biofouling solutions, as microelectrodes are more suitable towards in vivo 
work; in addition, a method of in situ recalibration of the biofouled PoPD-coated microelectrode 
was investigated. Fundamental studies described in this dissertation aim to increase the 
understanding of the biofouling phenomenon through in vitro simulation studies, as well as 
propose a method to account for and correct the consequences of this phenomenon.   
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Oxygen plays a vital role in many biological processes, and research has focused on 
developing methods of quantifying dissolved oxygen content. For example, the development of a 
reliable and minimally invasive oxygen sensor would be beneficial towards the diagnosis and 
treatment of ischemic stroke victims.  Electrochemical oxygen probes function by measuring the 
diffusion-limited current of the dissolved oxygen content, which is directly proportional to 
concentration.  Current electrochemical oxygen probes include the Licox probe: a small metal 
electrode covered by an oxygen-permeable membrane, with an internal electrolyte solution, and 
is the only oxygen probe approved for use in humans. An overlooked problem with traditional 
electrochemical oxygen probes is that the probe’s in vitro calibrated sensitivity value is assumed 
to match that for the in vivo environment.  In fact, common amongst in vivo implanted sensors is 
the susceptibility to adsorption of macromolecules, diminishing the sensitivity. This problem is 
partially solved by applying a protective membrane to the sensor. Furthermore, in vivo 
recalibration is not possible for oxygen sensors as is the case for glucose sensors. 
1.1.1 Electrochemistry of Oxygen 
The most practical and applied oxygen sensor is the design first proposed by Clark 
consisting of a noble metal electrode and a gas-permeable membrane separated by electrolyte 
solution.1 Oxygen permeates the membrane and diffuses through the electrolyte solution before 
reducing at the noble metal cathode, thereby producing a concentration-dependent current 
response. A sufficiently negative potential is applied to the cathode in order to reduce oxygen 
and produce a diffusion-limited current response. The oxygen reduction mechanism at the 




+ + 2𝑒− → 𝐻2𝑂2; 𝐸
0 = +0.695𝑉    (Reaction 1) 
𝑂2 + 4𝐻
+ + 4𝑒− → 2𝐻2𝑂; 𝐸
0 = +1.229 𝑉   (Reaction 2) 
 
However, on noble metal cathodes, the reduction of oxygen occurs negative of these potential 
values. It has been suggested that this potential shift is due to an adsorbed oxygen film on the 
noble metal surface, especially for the case of the platinum electrode. It has been noted that the 
gold electrode may not suffer from these adsorption effects (or very minutely) as evidenced by 
the reduction of oxygen not being as hindered as it is for Pt, likely because the interaction 
between oxygen and Au is weak.2-3 Electron transfer kinetics limit the rate of oxygen reduction 
at the cathode, except in the case at extremely negative potentials, in which the rate is diffusion-
limited. H2O2 intermediate formation (Reaction 1) occurs at -0.4V vs Ag/AgCl; at more negative 
applied potentials (-0.8V vs Ag/AgCl), Reaction 2 dominates. Whether or not peroxide is formed 
is dependent upon both the applied potential and the cathode material itself.4 For most practical 
purposes, Reaction 2 is used for Clark-type electrodes. 
1.1.2 Biofouling 
Biofouling is the adsorption of macromolecules such as proteins and cells onto the 
surface in the implanted probe. Due to the body’s immune response, the adsorption of molecules 
to the probe’s surface occurs within seconds to hours, followed by cell interrogation by 
macrophages, a possible attempt at phagocytosis, and eventual encapsulation of the implanted 
probe (~2 weeks).5,6 Encapsulation would result in the implanted probe becoming isolated from 
the bulk tissue, meaning that the sensor would only detect the analyte in the sectioned off region 
in which it was confined. The biofouling resulting from implanting a probe in vivo impairs the 
probe’s ability to function.  
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The main components of blood plasma and therefore likely contributors to biofouling 
include serum albumin and fibrinogen.7,8 Albumins function to regulate osmotic pressure of 
plasma by stabilizing the extracellular fluid volume, and also to transport small biomolecules 
such as lipids and steroids in the blood.9 Serum albumin is a dominant blood protein.  Serum 
albumin (Bovine serum albumin (BSA)) undergoes reversible adsorption depending upon what 
surface it is exposed to.10 The protein sequence and secondary structure of BSA was first 
proposed by Brown: composed of three domains, over which there are nine sulfide loops.11   The 
three dimensional structure was more difficult to obtain, and at physiological pH is known to be 
a heart-shaped protein an equilateral triangle with sides of 80 Å and 30 Å deep.  Compared to 
other proteins it is difficult to denature (80 oC) and changes structure with pH.    Most 
interestingly these conformational changes are reversible.  The protein presents itself as 
negatively charged, and the distribution of charge is evenly distributed over the surface.12  
Albumin is readily adsorbed to surfaces but can be displaced by other proteins. Both BSA and 
fibrinogen are known to adsorb onto gold.13-16 BSA is a globular protein of approximately 66 
kDa M.W.; fibrinogen is considerably larger at approximately 340 kDa, so one would expect 
fibrinogen to be a more robust foulant than BSA.17 Fibrinogen is a cell adhesive protein that is a 
major component in blood coagulation, and the third most prevalent protein in plasma with a 
concentration of 2.6-3.0 mg/mL.18 Fibrinogen is a “sticky,” high molecular weight protein that 
adsorbs to both hydrophilic and hydrophobic surfaces.19 For its size it has a low charge density 
but shows separate regions of positive and negative charge. At pH 7.4, the uncompensated 
charge per fibrinogen molecule is -7.6 from the Lorenz-Stokes relationship, which could explain 
the substantial adsorption onto neutral and positively charged surfaces.18 In addition, it has been 
shown that near the isoelectric point (5.8), fibrinogen adsorbs in multilayers due to the strong 
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lateral interactions and close packing, while at much higher and lower pH (>9 and <4), 
monolayers of fibrinogen are observed.18 19 
1.1.3 Polymer coatings on sensors 
Using a protective film over the sensor’s surface aids in diminishing biofouling effects, 
leading to a more stable and reliable sensor. In particular, polymer film coating holds the most 
promise in terms of long-term stability, coating thickness, and coating uniformity across the 
sensor surface. In addition, the use of polymer coatings allows for the incorporation of enzymes 
into the polymer matrix, thereby creating an enzyme-selective electrode; the most well-known of 
these enzyme-selective electrodes is the glucose sensor made by incorporating glucose oxidase 
into the polymer matrix. Many polymer coatings, such as Nafion coatings, have involved 
evaporative deposition, or dip coating. Electrochemical deposition, or electropolymerization, has 
the advantage over dip coating of selectively coating only the electrode surface, whereas dip 
coating will apply the polymer to the entire surface with which it comes into contact. With 
electropolymerization, multiple polymer coatings can be evaluated individually on 
microelectrode arrays (MEA). For example, one could study polyeugenol on one individually 
addressable electrode of a MEA, and polyaniline on a separate individually addressable electrode 
on the same MEA, without having to remove the sensor from the in vivo probe environment. 
Nafion has been a popular choice for polymer coatings. It has found uses in a wide range 
of applications, such as fuel cells, ion-selective and biosensors, and acid catalysis.20,21 Nafion 
employs electrostatic repulsion to selectively inhibit interferents from reaching the electrode 
surface. Nafion is generally successful at blocking negatively-charged electroactive interferents 
but tends to concentrate positively-charged species at the membrane surface, which can interfere 
with the analyte signal. Nafion is also susceptible to forming fractures in the membrane coating 
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if not stored in an aqueous medium, which would consequently allow interferents to pass through 
the membrane and contact the electrode surface.22 Nafion employs an evaporative deposition 
technique to polymerize onto surfaces, which is not applicable to the current research project. 
 Electropolymerized polymers are of primary interest for this project, including 
polyeugenol (PE) and poly(o-phenylenediamine) (PoPD). PE is a non-conducting, porous 
polymer that allows dissolved gases (such as O2) to diffuse readily across the membrane to the 
electrode while excluding larger molecules.23 Analyte response over PE-coated glassy carbon 
electrodes were found to have a high permeability to the target analytes (such as nitric oxide) 
compared to other polymer coatings (i.e. polyaniline and polypyrrole).24 It has also been used 
over graphite electrodes and shown to suppress the ascorbic acid response while enhancing the 
dopamine response, suggesting PE as a polymer of interest for in vivo sensors.25 PE has also 
been studied over gold disk electrodes and shown to have a good permeability to oxygen while 
producing a stable oxygen calibration when exposed to a biofouling environment.26 PE’s lack of 
conductivity has the advantage over conducting polymers which have high background current 
that masks an analyte’s signal at low concentrations. In this work, PE has been shown in 
preliminary data to have good oxygen permeability when electropolymerized on the MEA; 
however, it has also been shown to be stable for only 1-2 days, which is not applicable to longer-
term in vivo studies (>2 weeks).  
 PoPD has been used as a protective coating in various applications, such as biosensors, 
metals, and electronic devices.27,28 PoPD has been shown to be permeable to small molecules, 
namely hydrogen peroxide, but shows relatively low permeability to larger interferents.29 PoPD 
has been used extensively in enzyme sensors such as glucose sensors, suggesting that it is 
permeable to oxygen, as the (first generation) glucose oxidase enzyme requires oxygen to 
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function.30,31 PoPD is also thought to be one of the polymer coatings most likely to withstand 
long-term in vivo use.32 PoPD’s permeability to small molecules and long-term stability make it 
a good polymer to investigate for this current project. 
1.1.4 Polymer characterization 
 Characterization of the polymer films is accomplished through various techniques. The 
use of probe molecules has been previously shown to be a viable method of characterizing 
uniformity and completeness of film coatings.26 Probe molecules such as K3Fe(CN)6 and 
Ru(NH3)6Cl3 function to receive electrons from the bare (uncoated) electrode surface, thereby 
resulting in a current response signal characteristic of the probe molecule, and indicating if the 
polymer coating is nonuniform. Probe molecules are ineffective to adequately characterize 
electrode coatings of conducting polymers because the polymer will transfer electrons through 
the membrane directly to the probe molecule, and thereby generating a current response. This 
technique was used here for the characterization of polymer coating evenness, uniformity, and 
degradation. 
1.1.5 In situ recalibration theory 
External methods of calibration require removal of the probe from the test environment. 
By introducing a second, oxygen-generating electrode (GE) external to the polymer membrane 
working electrode (WE), oxygen can be generated and the new sensitivity determined. This 
method is an adaptation of previously published work using 2 mm gold electrodes;33 the 
innovation in this work was utilizing microelectrode arrays, and PoPD as the protective polymer 
coating on the working electrode. The theory of the in situ recalibration involves measuring the 
change in current at the detector electrode (ΔiDL) and current at the generator electrode (iGE) and 
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determining “ξ,” a parameter similar to collection efficiency. After fouling, the new sensitivity 






     (Equation 1) 
By utilizing this in situ recalibration method, the oxygen sensor’s change in sensitivity can be 
accounted for and corrected. However, the in situ calibration technique is not a magic solution 
that can correct for the most drastically fouled electrodes; it has its limitations just like any other 
technique. It is therefore first necessary to quantitate the sensitivity losses with extreme fouling, 
and test the maximum limit of fouling that the in situ calibration can recalibrate. 
1.2 Significance 
The objective of this research project is to develop a better understanding of biofouling 
and to contribute to knowledge of the field of in vivo oxygen sensors. The purpose of these 
studies is to quantify the sensitivity changes caused by biofouling of a membrane-coated oxygen 
sensor. Biofouling decreases the sensor’s sensitivity thereby inhibiting accurate O2 concentration 
readings. To attempt to minimize biofouling, a protective polymer is applied to the surface of the 
gold electrode via electropolymerization. Presently there are no means to recalibrate an in vivo 
oxygen sensor. One purpose of this project is to develop an in situ recalibration method for 
biofouled sensors. These projects accomplish successful application and characterization of 
protective polymer membranes, development of a systematic method for studying changes in 
sensitivity of implanted devices, and an in-depth discovery of the key components that contribute 
to biofouling, as well as a method for recalibration of biofouled oxygen sensors in situ. These 
advances could lead to improvements in oxygen sensors used in clinical applications. 
 9 
1.3 Overview of the Studies Described in this Dissertation 
Chapter 2 demonstrates the fundamental study of electropolymerized polymer on gold 
microband arrays for oxygen sensing. In this study, polyeugenol was electropolymerized onto 
gold microelectrode arrays and used for oxygen sensing. However, due to polymer instability, PE 
was not a viable option for application to in vivo sensors. 
Because polyeugenol was not applicable to long-term in vivo devices, a new polymer 
(PoPD) was investigated in Chapter 3. These experiments utilized 2 mm gold disc 
macroelectrodes in order to understand the behavior of PoPD on gold electrodes for oxygen 
sensing in the presence of biofoulants: BSA, fibrinogen, and rat brain homogenate. This study 
also simulated the in vivo recalibration practices typically used in the field of in vivo sensors, 
proving the extent of the problems associated with these current practices. 
Chapter 4 focuses on application of PoPD to microelectrode arrays for oxygen sensing in 
the presence of biofoulants: BSA, fibrinogen, and blood serum. These experiments also include a 
generation-detection of oxygen scheme, which can be used to predict a new sensor sensitivity 
when the sensor is biofouled and has a subsequent sensitivity change. 
Each chapter in this dissertation is written in a format that is compatible for publication in 
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2. Evaluation of Eugenol on Microelectrodes for Long-Term Stability, Coating 




Polyeugenol (PE) has been shown in previous work to be permeable to oxygen and 
effectively protect the oxygen electrode from biofouling using gold macroelectrodes. This work 
investigated PE as a possible protective polymer membrane coating for use with microelectrodes, 
as they are more applicable towards in vivo applications. These data show effective polymer 
adhesion to a gold microelectrode on a microelectrode array, PE’s permeability to oxygen via 
calibration curves, and effective blocking of the probe molecule ferricyanide. These data also 





Eugenol is the primary component of clove oil derived via hydrodistillation of Eugenia 
caryphyllata buds and leaves.1 Eugenol has been studied extensively for its wide uses in a variety 
of fields, such as pharmaceutics, agriculture, and cosmetic industries. It has been of particular 
interest for medicinal uses as an antibacterial, antifungal, anti-inflammatory,2-4 analgesic, anti-
oxidant,2, 5 and anticancer activities; it has also been studied as an antifumagant and repellant,6 
anticarcinogen,7 anticonvulsant,8 and antimutagen.9  
Eugenol is an allyl chain-substituted guaiacol (Figure 2.1) that is weakly acidic, slightly 
soluble in water, and soluble in organic solvents; it is a pale to yellow liquid with a distinct clove 
smell and spicy taste.1 Eugenol can be produced synthetically via the allylation of guaiacol with 
allyl chloride.1 It is thought to have antimicrobial, chemopreventive effects, and antioxidant 
activity due to the phenolic group.10  
The combination of eugenol with conventional antibiotics is thought to have synergistic 
effects. Hemaiswarya et al noted that 1 mM eugenol damaged nearly 50% of the Gram-negative 
bacterial membrane, which allowed increased penetration of vancomycin and -lactam 
antibiotics and therefore an increased microbial effect.11 Eugenol combined with ampicillin and 
gentamicin exhibited a higher kill rate of bacteria over 60 minutes than with antibiotics alone.12 
Significant synergistic effects against Escherichia coli were noted when eugenol was combined 
with cinnamaldehyde, thymol, carvacrol, and their combinations, even though eugenol itself has 




Figure 2.1 Molecular structure of eugenol monomer. Image obtained from MP Bio, 
http://www.mpbio.com/product.php?pid=02151106&country=223 (accessed April 7, 2017). 
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The mechanism of eugenol’s apparent synergistic effect is proposed to be due to the induced cell 
lysis causing leakage of proteins and lipid contents, as well as damage to both cell wall and 
membrane of Gram-negative and Gram-positive bacteria.14 In addition, eugenol could be added 
to food products as an antimicrobial agent in order to suppress the production of exotoxins by S. 
aureus.15 
Eugenol has exhibited antifungal properties against a wide variety of species.16-18 
Eugenol has an even more potent activity than some known synthetic antimicrobial compounds 
and is applicable to a wide spectrum of Aspergillus species.19 Eugenol is lipophilic, and can 
therefore easily get between acyl chains of the cell membrane to modify the permeability of cell 
membranes and disturb cell growth.20-21 Eugenol has proven to be highly toxic to C. albicans, 
affecting the membrane integrity and causing arrest of the cell cycle, thereby killing 99.9% 
within 7 minutes following exposure.22 In addition, eugenol was used prophylactically and as a 
treatment for experimental vaginal candidiasis with immunosuppressed rats; results show that 
after 10 days of inoculation, eugenol reduced the number of colonies of C. albicans by 98.9%.23 
Eugenol also shows an antifungal synergistic effect. Eugenol and methyleugenol were tested 
with fluconazole (an antifungal drug) against various fluconazole-sensitive and fluconazole-
resistant C. albicans strains, which resulted in all strains exhibiting susceptibility; these results 
suggest that eugenol/methyleugenol could be used in combination with traditional antifungal as 
an alternative treatment.24-25 
Eugenol has been used extensively as an analgesic for dental, antinociceptive, and 
anesthetic applications. Eugenol (in doses of 50, 75, and 100 mg/kg) was evaluated as an oral 
analgesic for mice via the acetic acid-induced abdominal writhing method; eugenol was shown 
to have a significant effect over a period of 30 minutes in a dose-dependent manner on the 
 19 
reduction of pain as measured by the number of contractions of the body.3, 26 Lee et al noted that 
eugenol inhibited high-voltage-activated Ca2+ channel (HVACC) currents in dental primary 
afferent neurons, which are composed of primarily pain neurons; these results suggest that 
HVACC inhibition may play a role in eugenol’s apparent analgesic properties.27 Eugenol has 
also been studied as an anesthetic using various fish models; results found that eugenol has a 
strong anesthetic effect28-31, but sometimes with slow recovery.31  
New methods for treating or preventing cancer is a widely studied and necessary field of 
research interest. Specifically, focus has been on compounds derived from natural sources, to 
replace conventional anticancer treatments that often have harmful side effects. Eugenol has 
been studied alone and in conjunction with a conventional chemotherapeutic drug (gemcitabine) 
against HeLa cells (an immortal cell line derived from Henrietta Lacks’s cervical cancer cells); 
eugenol showed a dose-dependent selective cytotoxicity to the HeLa cells as compared to normal 
cells, and the combination treatment of eugenol (150 M) and gemcitabine (15 M) decreased 
HeLa cell viability to 47%, an improvement over eugenol alone (84%) and gemcitabine alone 
(51%).18 Eugenol also induced apoptosis of colon cancer cells, increasing the lipid layer break 
and reducing the intracellular non-protein thiols.32 Eugenol was an effective inhibitor of 
melanoma cell proliferations, delaying tumor growth and effecting a 40% decrease in tumor size; 
it also seemed to impact metastasis, as 50% of the control group died due to metastasis, while 
zero in the treatment group were affected by metastasis.33 
A mechanism for polymerization has been proposed and is similar to those described for 
oxidative polymerization of porphyrins,34 vanillin,35 guaiacol,36 and epidotoxin.37 Eugenol 
monomer is polymerized to polyeugenol (PE) via oxidative polymerization though the hydroxyl 
group in alkaline solution.38-39 In alkaline solution, the phenol group exists as the phenolate ion 
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(I) (Fig. 2.2) which is readily oxidized via a one-electron transfer to generate a free radical (II).38 
Then, interacting with a methoxy group on a monomer molecule, methanol is eliminated via 
alkaline hydrolysis and generates an anion radical (III) which is then converted via a one-
electron reaction to o-quinone (IV).38 The mechanism for polymer growth on the electrode 
surface is less clear. Possible mechanisms include: a free radical step-growth polymerization 
initiated by (II);40 a Diels-Alder reaction between o-quinone (IV) and allyl C=C bound giving a 
1,4-benzenedioxane subunit;41 dimerization of radical (II);42 creation of lignan-like subunits by 
oxidative coupling of substrate molecules;42-43 or hydroxylation of (IV) leading to p-quinone.38, 44 
Polyeugenol is a non-conducting, porous polymer that allows dissolved gases (such as 
O2) to diffuse readily across the membrane to the electrode while excluding larger molecules.45 
PE has been applied to sensors for a variety of applications. PE has been applied to platinum,39, 
46-48 glassy carbon,46 and carbon fiber microdisk48 electrodes for nitric oxide sensing. PE has also 
been utilized for dopamine detection,38, 49 and retained 85% of the initial dopamine response after 
10 days.38 Although PE has been used in detection of larger molecules,50 nitric oxide sensor 
applications show PE’s permeability to small molecules and therefore possible applications to 
oxygen sensors. PE’s lack of conductivity has the advantage over conducting polymers with high 
background current that could mask an analyte’s signal at low concentrations. PE films are 
typically used for analytes detected via oxidation, but not used in many studies utilizing negative 
potentials.47 Paul et al were successful in studying PE over gold macrodisk electrodes; the 
electrodes were shown to have a good permeability to oxygen while producing a stable oxygen 
calibration when exposed to a biofouling environment.51 PE showed great promise for 
applications to microelectrode array oxygen sensor, but a stability study had not been done 
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Figure 2.2 Proposed mechanism for eugenol polymerization. Image obtained from: 
Ciszewski, A.; Milczarek, G., Polyeugenol-modified platinum electrode for selective 




2.3 Materials and Methods 
 2.3.1 Reagents 
NaCl (VWR), KCl and NaHCO3 (EMD), CaCl2 (Amresco), D-glucose (Alfa Aesar), 
MgCl2 and NaH2PO4 (Sigma-Aldrich) were obtained and used as received. The aCSF solution 
was prepared using the following concentrations of components: 119 mM NaCl, 2.5 mM KCl, 
1.3 mM MgCl2, 2.5 mM CaCl2, 1 mM NaH2PO4, 26.2 mM NaHCO3, and 10 mM D-glucose.52 
Eugenol monomer (99%) was obtained from Alfa Aesar and used as received without further 
purification. Unless otherwise stated, a Ag/AgCl in sat’d KCl reference electrode was used in all 
experiments. 
 2.3.2 Working electrode preparation 
Microelectrodes used in the study consisted of an array of sixteen interdigitated 
microbands (2 mm long, 25 µm width and 25 µm gap) on a 1 in x 1 in silicon substrate; an 
insulating layer of benzocyclobutane (BCB) covered the entire chip except the exposed array and 
contact pads. The eugenol polymerization was accomplished on a single gold electrode of the 
MEA using 10 mM eugenol in 0.1 M NaOH and sweeping the potential from 0.0 V to 0.7 V at a 
scan rate of 100 mV/s for 40 cycles.51 
 2.3.3 Oxygen calibration curves 
The current response from the oxygen cyclic voltammograms (CVs) were obtained on a 
CHI 830 potentiostat at -0.6 V vs Ag/AgCl in sat’d KCl reference at increasing dissolved oxygen 
concentrations. The dissolved oxygen concentration was measured with a YSI model 55 oxygen 
meter. The solutions were purged of dissolved oxygen by bubbling nitrogen through the solution. 
The oxygen CVs were obtained versus Ag/AgCl (in sat’d KCl) reference and platinum flag 
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auxiliary electrodes. The oxygen calibration curve was constructed (Fig. 2.3) by analyzing the 
current response from the oxygen CVs at -0.6 V. 
 2.3.4 Polyeugenol stability 
The PE-coated electrode was compared to a bare electrode on the same array by cyclic 
voltammetry in 5 mM K3Fe(CN)6 in 0.1 M KCl from 0.5 V to -0.2 V vs Ag/AgCl in sat’d KCl 
reference using a scan rate of 100 mV/s for one cycle. The integrity of the PE coating was 
investigated using ferricyanide as a probe molecule to assess imperfections in the polymer layer. 
2.4 Results and Discussion 
The permeability of oxygen through the PE coating was investigated. An oxygen 
calibration curve was constructed in artificial cerebrospinal fluid (aCSF) solution to compare PE-
coated and bare electrodes. The PE-coated and bare electrodes exhibited similar sensitivities 
confirmed by Student’s t-test (0.110 ±0.004A/ppm and 0.107±0.005 A/ppm, respectively), 
suggesting that oxygen is readily permeable through the protective PE film (Fig. 2.3). 
Potassium ferricyanide, K3Fe(CN)6, was used as a probe molecule to test the uniformity 
of the PE coating. If the ferricyanide molecule is able to contact the surface of the electrode, a 
typical ferricyanide signal is observed (Fig. 2.4, bare); the high magnitude of current is likely a 
result of the MEA chip being cleaned in RCA-1 solution prior to use, which has been shown to 
remove the insulating BCB layer, thereby exposing more than the 2 mm as it was designed. 
Nevertheless, the comparison of PE-coated and bare microelectrodes (Fig. 2.4) exhibits the loss 
of ferricyanide signal after polymerization, suggesting that the PE coating was complete; there is 
also an increase in background charging current for the PE-coated electrode (0.92 A) due to the 
presence of the polymer membrane on the electrode surface. An additional CV was obtained on 
the PE-coated electrode 24 hours later (Fig. 2.5); these data show a ferricyanide signal after only 
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24 hours as can be seen by the change in shape to a more sigmoidal signal that is indicative of a 
ferricyanide signal. These characterization studies indicate that the PE coating degrades over 
time. A possible reason for why other researchers have shown PE stability over time, a direct 
contradiction to the findings in this study, is that previous work has not focused on using 
negative applied potentials;47 the extreme negative applied potential could induce a local change 
in the polymer structure that is exacerbated with continued use. 
Using the Randles-Sevcik equation (Eq. 2.1), a total electrode surface area of 1.22E-2 
cm2 was calculated for the bare electrode in Fig. 2.4; this differs from the expected surface area 
of 5E-4 cm2, assuming a 25 μm x 2 mm MEA individual electrode. This difference is due to the 
insulating BCB layer detaching from the chip during a cleaning procedure, leaving more of the 









∗     (2.1) 
ip is the peak current; n is the # of moles; A is the surface area of electrode; Do is the diffusion 
coefficient;  ν is the scan rate; Co* is the concentration of electroactive species in the bulk. 
In regards to Fig. 2.5, the presence of a slightly sigmoidal curve indicates microelectrode 
behavior and incomplete polymer coverage in which electron transfer is blocked and non-linear 
diffusion effects are observed;53 this could be due to many small pores or a few large cracks in 
the polymer membrane. Assuming that the current response is due to the former, an average 
electroactive pore size was calculated to be 6.94 nm, with an average distance between pores of 
70.97 nm according to the following equations derived for cases in which the electron transfer is 
blocked by a film that almost completely covers the electrode surface:53 










    (2.2) 
𝑅𝑎 = 𝑅𝑜(1 − 𝜃)
1
2⁄       (2.3) 
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where Ro is the distance between active sites; Ra is the size of active site; θ is the fractional 
coverage of the electrode; D is the diffusion coefficient; ks,0a,p is the rate constant at an unblocked 
electrode (0.095 cm/s);54-55 α is the transfer coefficient (0.55);54-55 E1/2 is the half-wave potential; 
E0 is the standard reduction potential, and 𝒻(1 − 𝜃) assuming a disc-type active site is:53 
𝒻(1 − 𝜃) = 0.3(1 − 𝜃)
1
2⁄      (2.4) 
For this calculation, the average of ic and ia current at 0 V was obtained, to account for the high 
capacitive current for both a bare electrode (Fig. 2.4) and a PE-coated after 24 hours (Fig. 2.5), 




      (2.5) 
A pore size of 6.94 nm is in good agreement with the concept that the current response is 
due to many small pores acting as additive microelectrodes. These calculations are approximate, 
as they assume a hypothetical averaged distribution in which the dimensions of actives sites and 




Figure 2.3 Oxygen calibration curves of PE-coated (blue diamonds) and bare (orange 
squares) electrodes in aCSF; Ag/AgCl in sat'd KCl reference, n=1. Bare and PE-coated 
electrodes exhibit the same sensitivity value within experimental uncertainty: PE-coated 
sensitivity of 0.110±0.004 µA/ppm, bare electrode sensitivity of 0.107±0.005 µA/ppm via 






















Figure 2.4 Comparison of ferricyanide signal for PE-coated and bare microelectrodes on 
the MEA; electroactive surface area of bare electrode: 1.22E-2 cm2, much larger than the 
expected 5E-4 cm2 for a single electrode finger. The difference is expected to be caused by 






















Figure 2.5 Stability study of the PE coating on a single gold electrode of the MEA; average 
electroactive pore size was calculated to be 6.94 nm, with an average distance between 




















Potential (V vs Ag/AgCl in sat'd KCl)
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2.5 Conclusion 
PE-coated and bare microelectrodes exhibited similar sensitivities to oxygen. Potassium 
ferricyanide, used as a probe molecule, exhibited uniform PE coating, followed by a nonuniform 
PE coating after 24 hours. As the PE coating was proven to be mechanically unstable, biofouling 
studies were not conducted on a PE-coated microelectrode. This is the first work utilizing probe 
molecule ferricyanide to test the uniformity of a PE coating. While the PE film did show oxygen 
permeability, the degradation of the film after only 1 day makes PE unsuitable for our work 
towards in vivo oxygen sensors. 
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3. Long-term Drifts in Sensitivity Caused by Biofouling of an Amperometric Oxygen 
Sensor 
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This chapter is reformatted from an article published in Electroanalysis with permission from 
John Wiley & Sons, Inc. publisher. The original publication can be found as “M. M. Patrick, J. 




Changes in oxygen sensitivity of an poly(o-phenylenediamine) (PoPD) coated gold 
electrode was determined by constructing calibration curves in vitro. Oxygen sensitivities 
recorded in the presence of biofoulants were significantly different from those recorded in 
buffer; however, PoPD demonstrated its effectiveness in providing some resistance to changes in 
oxygen sensitivity over time compared to a bare electrode. Three sets of PoPD-coated electrodes 
were calibrated in simple electrolyte of phosphate buffered saline; each set yielding an average 
oxygen sensitivity of 0.58±0.03 mA/ppm, 0.68±0.01 mA/ppm, and 0.48±0.01 mA/ppm (n=4), 
which shows the electrode to electrode variation in the PoPD-coating/ electrode. These sets were 
correspondingly exposed to bovine serum albumin, fibrinogen, rat brain homogenate. Exposure 
to these biofoulants resulted in decreases in sensitivity ranging from 26–35% after immediate 
exposure. Furthermore, long-term exposure to some biofoulants causes significant decreases in 
sensitivity over a time period of 14 days. We also estimated through in vitro exposure to rat brain 
homogenate the errors that might be associated with current methods of calibration. Sensitivities 
to oxygen determined by precalibration resulted in a 50% error from the sensitivity found in 




Oxygen is of critical importance in many biological processes. Clinically, decreased 
dissolved oxygen levels in the brain are connected to brain damage caused by ischemic strokes 
or trauma. In general, patients with higher levels of brain oxygen tend to survive, while 
patients with lower brain oxygen levels do not. It is therefore vital to monitor the oxygen 
concentration in the brain in order to care for brain trauma victims. An absolute threshold value 
of brain oxygen is a critical piece of information required by clinicians; below this value, clinical 
intervention would need to take place. However, there has been difficulty obtaining this 
threshold value, as the oxygen values vary significantly from patient to patient (from 8.5 to 20 
mmHg). Indeed, when the absolute readings between laboratories are considered (average varied 
between 0.5 and 5.6 mmHg), it was concluded that only differences in the probes or human error 
could account for these differences.1 It is believed that these oxygen variations are a result of a 
change in the probe’s sensitivity occurring after implantation, and the procedures used with in 
vitro calibration. There is anecdotal evidence for this, but as of yet there has not been a 
comprehensive study to prove this phenomenon, at least for oxygen. Currently the only invasive 
oxygen probe approved for clinical use is based on the Clark-type oxygen electrode design.2 The 
Clark-type electrochemical oxygen probe measures the diffusion-limited current for the 
reduction of dissolved oxygen, which is directly proportional to the concentration of dissolved 
oxygen. The most common Clark-type electrode is composed of a metal cathode (gold) and a 
reference electrode (Ag/ AgCl) behind a thin layer of electrolyte solution and covered with a 
protective semi-permeable membrane.3 However, Clark-type electrodes used in clinical work are 
unsuitable for use in small animals such as rats, largely due to their size and poor spatial 
resolution for obtaining measurements in distinctive brain regions.2  
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Unlike the cathode type, the Clark-type oxygen sensor does not lend itself to mass 
production, or inclusion into sensor arrays; advances in in vivo sensing are most likely to be 
made in both of these areas. Because of these limitations, the work presented in this study 
utilized a cathode-type electrode with a polymer membrane coating. Membranes for the cathode 
type oxygen sensor include: polyethylene, polypropylene, cellulose acetate, Teflon, and 
polystrol.4 Poly-o phenylenediamine (PoPD) has been studied for use in glucose oxidase sensors5 
and is thought to be suitable for long term use in vivo.6 All membrane covered sensors suffer 
from biofouling, instability, and loss of calibration to some degree. The measurements are 
suspected to be off, but by how much? This work reports the quantitative changes in sensitivity 
of a cathode type oxygen sensor due to long term exposure to various suspected foulants. 
The membrane-covering thwarts biofouling of the bare electrode, lengthening useful life 
of the sensor. As with all amperometric sensors, the sensitivity to the analyte diffusing through 
the membrane is set by the membrane’s permeability. All implanted devices are subject to 
responses from the body, including wound healing, leukocytes, protein adsorption, and eventual 
encapsulation.7-9 Adsorption of proteins to surfaces occurs rapidly;10 typically followed by 
protein denaturation or conformational changes.11-12 In addition, the immune response’s effect on 
implanted sensors is an ongoing and oft-studied problem. The adsorption of biomolecules, 
biofouling, of the membrane alters the permeability of the membrane, and hence the calibration 
of the sensor.13 Although biofouling has not been directly observed in vivo, the characterization 
of the biofouling mechanism has been under study for years.14 
There are a few quantitative studies that highlight changes in sensor sensitivity caused by 
biofouling. Glutamate sensors constructed by m- and o-phenylenediamine entrapment of the 
enzyme showed decreases in sensitivity and selectivity after in vivo implantation in less than 4 
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hours.15-16 Electrodes with Nafion/PoPD polymer films stored in biofoulant bovine serum 
albumin (BSA) protein and L-a-phosphatidylethanolamine lipid solutions for 24 hours exhibited 
a 38% decrease in sensitivity to nitric oxide; additional sensitivity changes were not observed 
after 72 hours.17 Liu et al employed a BSA pretreatment as a method to minimize biofouling 
(blocking) of in vivo carbon fiber electrode dopamine sensors which exhibited similar results for 
pre- and postcalibration.18 Klueh studied the biofouling of glucose sensors in vitro, outlining the 
effects blood components have on the sensitivity to glucose.7, 19 A number of strategies have 
been investigated to attempt to minimize biofouling of electrochemical devices, but more 
research is needed to better understand this phenomenon.20 
There have been many coating methods that attempt to minimize the effect of biofouling 
on the oxygen sensor response. This includes a nitric oxide generation that actively inhibits 
biofouling21, as well as various polymer membranes that resist fouling.22 One method to 
minimize the effects of biofouling on bare electrodes has been to apply a large oxidizing or 
reducing potential directly before an electrochemical measurement in order to detach any 
adsorbed and undesirable components from the surface of the electrode (organic, aliphatic 
compounds).23-25 Alternatively, there was also a reported method that changed the morphology of 
a gold electrode itself in order to minimize the effects of biofouling.26 A few reports note success 
using zwitterionic-modified sensors.27-29 Coating zwitterionic poly(carboxybetaine) hydrogel 
onto a glucose sensor minimized blood-materials interactions and extended the life of the 
sensor.30 Although there are some successes, biofouling of sensor membranes remains 
problematic. Some investigators have come to the conclusion that the development of a non-
biofouling membrane can never be realized.19 If this is the case then it would be useful to 
quantitatively measure sensitivity changes caused by biofouling.  
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Here we show changes in oxygen sensitivity and permeability through the PoPD 
membrane due to exposure to various biofoulants, including BSA, fibrinogen, and rat brain 
homogenate. We also note the stability of the PoPD-modified electrode over a 14 day period. 
Oxygen sensitivity of a bare gold electrode was compared to that of a PoPD-coated gold 
electrode. Finally, we present in vitro data that estimate the errors for in vivo measurements 




NaCl, KCl, MgCl2, CaCl2, NaH2PO4, Na2HCO3, D-glucose, o-phenylenediamine (oPD) 
monomer, BSA, fibrinogen, and phosphate buffered saline (PBS) were obtained from Aldrich, 
Alfa Aesar, Amresco, EMD chemicals, Fisher Scientific, J.T. Baker, Sigma, or VWR and were 
used as received. Solutions of oPD monomer (5 mM) were prepared in 10 mM PBS. Brain tissue 
was obtained from male Sprague-Dawley rats used for other IACUC-approved experimental 
studies and were provided by Dr. Julie Stenken of the University of Arkansas. All animal 
protocols followed the guidelines set forth by the National Institutes of Health for the Care and 
Use of Laboratory Animals. Immediately after harvest, brain tissue was homogenized in a 50% 
wt solution of 10 mM PBS using a Biospecs Tissue Tearor; the resulting solution was divided 
into 1 mL aliquots. 1% (wt/wt) solutions of BSA, fibrinogen, and homogenized rat brain were 
prepared in HPLC grade water. Unless otherwise stated, experiments were carried out in PBS 
solution, pH 7.4 (140 mM NaCl, 10 mM phosphate buffer, 3 mM KCl). Biofouling studies with 
fibrinogen were carried out in artificial cerebrospinal fluid (aCSF) (119 mM NaCl, 2.5 mM KCl, 
1.3 mM MgCl2, 2.5 mM CaCl2, 1 mM NaH2PO4, 26.2 mM Na2HCO3, and 10 mM D-glucose). 
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3.3.2 Working Electrode Preparation 
 
The 2 mm gold disk working electrodes were obtained from CH Instruments. They were 
treated by mechanical polish via Buehler alumina polish of 5.0 mm, 1.0 mm, 0.3 mm, and finally 
0.1 mm grits, and rinsed thoroughly with HPLC grade water. Polymerization solutions of 5 mM 
oPD monomer were prepared by dissolving in 10 mM PBS and sonicating for 10 minutes.31-32 
PoPD-coated gold electrodes were produced by potential cycling from 0.25 V to +1.3 V vs 
Ag/AgCl (in sat’d KCl) reference for 30 cycles.33 Electrodes were rinsed with HPLC grade water 
post-polymerization to remove loosely bound monomer. Unless otherwise stated, a CH 
Instruments 1030 A potentiostat, Ag/AgCl (in sat’d KCl) reference electrode, and platinum flag 
counter electrode were used for all experiments. 
The electrolyte solutions were purged of oxygen by bubbling nitrogen and then ambient 
oxygen was allowed to re-dissolve. The dissolved oxygen concentration was measured using a 
YSI Pro20 oxygen meter (Yellow Springs, OH). Cyclic voltammograms (CVs) of varying 
dissolved oxygen concentrations were obtained at PoPD-coated and bare Au electrodes by 
potential cycling from 0 V to 1.0 V vs Ag/AgCl in sat’d KCl reference. Calibration curves were 
constructed by plotting the current value at -0.6 V vs Ag/AgCl in sat’d KCl reference against the 
dissolved oxygen concentration. Sensor sensitivity to oxygen is taken as the slope of this line. 
3.3.3. PoPD Film Stability 
 
The stability of the PoPD polymer film was studied over time by potential cycling from 
0.5 V to -0.2 V vs Ag/AgCl in sat’d KCl reference using 5 mM K3Fe(CN)6 as a probe molecule 
in 10 mM PBS. The K3Fe(CN)6 peak current at +0.2 V vs Ag/AgCl in sat’d KCl reference from 
the resulting CV was plotted versus time to show the stability and integrity of the PoPD coating. 
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3.3.4 Oxygen Sensitivity with Exposure to Biofoulants 
 
PoPD-coated and bare electrodes were exposed to biofoulant solutions for varying 
duration and oxygen calibration curves constructed as described above. The resulting 
sensitivities from the calibration curves at various duration of biofoulant exposure were then 
plotted versus time, giving an indication of how the oxygen sensitivity changes over time with 
exposure to biofoulant. 
3.4 Results and Discussion 
Biofouling is well known to diminish the sensitivity of amperometric sensors. The 
hypothesis is that if a biofoulant adsorbs on a sensor surface, the rate of oxygen reduction will be 
impeded, and thus the oxygen sensitivity will decrease. The data presented in this study provides 
estimates about the magnitude of errors arising from in vivo oxygen sensors. 
We chose to electropolymerize PoPD as this polymer was reportedly one of the most 
resistant to biofouling in vivo.5-6 Electropolymerization offers the advantage of uniform and 
repeatable polymer coatings, and it also allows for selective coatings on individual members on 
an electrochemical array.34 
3.4.1 PoPD Film Stability 
The PoPD-coated electrodes were continuously exposed to 10 mM PBS for a period of 
two weeks. The long-term stability, e. g. cracking, or loss of adherence to the electrode, was 
determined by cyclic voltammetry of [Fe(CN)6]3- (ferricyanide) at a bare and a PoPD-coated 
gold electrode; ferricyanide is an electrochemical probe molecule that gives a current response 
when in contact with an uncoated electrode surface. As Figure 3.1 shows, the bare electrode 
records larger but irregular ferricyanide current signals over time, while the PoPD-coated 
exhibits a relatively constant peak signal value at a significantly lower current value.  
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Figure 3.1 PoPD membrane stability in 10 mM PBS. PoPD-coated (n=3) and bare (n=1) 
electrodes are represented by open and solid diamonds, respectively. Inset is an expanded 
view which shows the day-to-day variations in the PoPD-coated electrode; reference 
electrode: Ag/AgCl in sat’d KCl. 
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This indicates that the PoPD coating is stable, as the probe molecule is unable to contact the 
electrode surface generating a current response. There are slight (~4%) day-to-day variations in 
the PoPD-coated electrode as shown by the inset in Figure 3.1; these variations will be discussed 
in a later section. Ferricyanide peak current (@+0.2 V) over time indicates a stable and uniform 
PoPD coating; bare electrode data indicates adsorption of undesirable molecules to the surface of 
the gold, altering the peak current over time. 
Alternatively, the same probe molecule can be used to follow the passivation of an 
electrode from biofouling. Ferricyanide has been used in several reports to study the effect of 
biofoulants on the activity of an electrode. For example, Wallace et al. noted a decrease in peak 
current and increase in peak splitting for ferricyanide when the gold electrode was incubated in 
human serum albumin and immunoglobulin G.35 After 10 minutes, the peak currents were 
“indistinguishable from the background charging current,” implying that the adsorbed protein 
hindered ferricyanide redox capability.35 
A representative oxygen CV is shown in Figure 3.2. The increased magnitude of current 
on the PoPD-coated CV is due to increased charging current. The lack of a steady-state oxygen 
current plateau is due to the continuous diffusion of oxygen through the membrane. Such CVs 
were used to construct calibration curves by plotting the reduction current at -0.6 V against the 
dissolved oxygen value. 
PoPD-coated electrodes not only show periodically longer stability than bare electrodes, 
but also retain permeability to oxygen. Figure 3.3 shows an overlay of oxygen current values 
taken at -0.6 V on PoPD-coated electrodes at 2.00 ppm dissolved oxygen, showing the day-to-
day variation of the sensor current.36 After day 3, the variation in the current levels increases 
indicating changes in the PoPD membrane between the three replicate electrodes studied. 
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3.4.2 Oxygen Sensitivity Changes with Exposure to BSA 
 
Serum albumin is a dominant blood protein. Serum albumin undergoes reversible 
adsorption depending on the type of surface it is in contact with.37 The protein sequence and 
secondary structure of BSA were firstly proposed by Brown to be composed of three domains, 
over which there are nine sulfide loops.38 At physiological pH, the three-dimensional structure is 
known to be a heart-shaped protein with an equilateral triangle of 80 Å and 30 Å deep. 
Compared to other proteins it is difficult to denature (80°C), and changes conformational 
structure with varying pH. Most interestingly these conformational changes are reversible. The 
protein presents itself as negatively charged, and the distribution of charge is evenly distributed 





Figure 3.2 Representative cyclic voltammogram (CV) of ambient dissolved oxygen (6.50 
ppm) in 10 mM PBS of PoPD-coated (solid line) and bare (dotted line) electrodes, which 
shows the typical reduction waves of oxygen at a gold electrode in neutral phosphate 




















Potential (V) vs Ag/AgCl in sat’d KCl
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Figure 3.3 PoPD-coated electrode day-to-day variation. The current response at -0.6 V vs 
Ag/AgCl in sat'd KCl reference at 2.00 ppm dissolved O2 in aCSF (n=3, closed diamonds) 
and with BSA added (n=3, open diamonds). The line serves only to aid the eye. 
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Figure 3.4 shows a representative oxygen calibration curve comparing PoPD-coated 
electrodes in control electrolyte and after immediate incubation in 1% BSA, where the shown 
error bars represent the electrode-to-electrode variation. The loss in sensitivity after BSA 
exposure (decreased slope of open diamonds as compared to closed diamonds) is assumed to be 
caused by BSA adsorbing to the PoPD film and impeding the diffusion of oxygen to the 
electrode.  
Each point in Figure 3.5 represents the sensitivity of the oxygen sensor taken as the slope 
of the calibration curve (such as those shown in Figure 3.4); each data point represents the slope 
of the calibration curves (ordinate) obtained after the electrodes were incubated for a specific 
time (abscissa) in either aCSF or aCSF/BSA. Immediately upon exposure (<1 hour) to BSA in 
aCSF (Day 0 in Figure 3.5), the oxygen sensitivity for the PoPD-coated electrode shows a 
decrease in sensitivity of 46% (0.59±0.01 mA/ppm, and 0.32±0.01 mA/ppm). After 1 day of 
exposure to BSA in aCSF, the oxygen sensitivity increases to within 6% of the control values for 





Figure 3.4 Representative oxygen calibration curve of PoPD-coated in control aCSF 
electrolyte (solid diamonds, n=3) and in test solution aCSF/BSA (open diamonds, n=3) in 10 
mM PBS immediately after exposure to biofoulant, BSA (t=0 days). The sensitivities are 
taken as the slope of the resulting calibration curve; in aCSF: 0.590.01 mA/ppm O2, in 
aCSF/BSA: 0.320.01 mA/ppm O2; Ag/AgCl in sat’d KCl reference electrode. 
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Figure 3.5 Oxygen sensitivity over time of PoPD-coated electrodes in control aCSF 
electrolyte (solid diamonds, n=3) and in test biofoulant aCSF/BSA solution (open 




The oxygen sensitivity of a bare gold electrode exposed to BSA follows the same trend as 
that for a PoPD-coated electrode. Immediately upon exposure to BSA the bare electrode (data 
not shown, n=1) shows a 51% decrease in sensitivity compared to the control (0.70 mA/ppm to 
0.34 mA/ppm); after 1 day of exposure the bare electrode shows a 11% decrease in oxygen 
sensitivity (0.70 mA/ppm control to 0.62 mA/ppm fouled). This indicates that both the PoPD-
coated and bare electrodes recover from fouling of BSA after 1 day. These results indicate that 
BSA is likely not the primary fouling component causing significant errors after time periods 
longer than 1 day. These results are in agreement with Bolger, et. al, who reported data after only 
24 hours of BSA exposure on a PoPD-coated platinum microelectrode.40 This is also consistent 
with the adsorption behavior of BSA mentioned above. The PoPD coating resists changes in 
oxygen sensitivity due to BSA fouling as compared to a bare electrode; however, PoPD does not 
eliminate the effects of fouling entirely. 
3.4.3 Oxygen Sensitivity Changes with Exposure to Fibrinogen 
 
Fibrinogen is a known biofoulant and is therefore frequently used in biofouling studies. 
Both BSA and fibrinogen are major components in blood plasma and are known to adsorb onto 
gold.35, 41-43 BSA is a globular protein of approximately 66 kDa M.W.; fibrinogen is considerably 
larger at approximately 340 kDa.44 Fibrinogen is a cell adhesive protein that is a major 
component in blood coagulation, and the third most prevalent protein in plasma with a 
concentration of 2.6-3.0 mg/mL.45 Fibrinogen is a “sticky,” high molecular weight protein that 
adsorbs to both hydrophilic and hydrophobic surfaces.46 For its size it has a low charge density 
but shows separate regions of positive and negative charge. At pH 7.4, the uncompensated 
charge per fibrinogen molecule is 7.6 from the Lorenz-Stokes relationship, which could explain 
the substantial adsorption onto neutral and positively charged surfaces.45 In addition, it has been 
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shown that near the isoelectric point (5.8), fibrinogen adsorbs in multilayers due to the strong 
lateral interactions and close packing, while at much higher and lower pH (>9 and <4), 
monolayers of fibrinogen are observed.45-46 The experimental pH presented here (7.4) should 
lead to strong adsorption of fibrinogen to the polymer surface. Furthermore, it has been shown 
that fibrinogen exhibits strong and spontaneous adsorption onto gold substrates that are 
negatively polarized, which is the case in the work presented here.47 
For brevity, the oxygen calibration curves for fibrinogen and rat brain homogenate 
biofouling studies have been omitted, and we only report the sensitivities found from the 
calibration curves. As shown in Figure 3.6, the PoPD-coated electrode (n=4) exhibited a 
decreased oxygen sensitivity when incubated in 1% fibrinogen solution. Immediately following 
fibrinogen exposure, the PoPD-coated electrode showed a 17% decrease in oxygen sensitivity 
(0.48±0.02 mA/ppm, as compared to the control electrolyte sensitivity of 0.58±0.02 mA/ppm); 
after prolonged exposure (19 days), the PoPD-coated showed only a 19% decrease (0.52±0.01 
mA/ppm as compared to control electrolyte at 19 days 0.65±0.02 mA/ppm). The bare electrode 
(data not shown, n=1) showed a 26.9% decrease in oxygen sensitivity (from 0.67 mA/ppm to 
0.49 mA/ppm); after 19 days of exposure the bare electrode showed a 52% decrease (from 
control value 0.91 mA/ppm to 0.44 mA/ppm after fibrinogen exposure). This suggests that PoPD 
protects the electrode surface from fibrinogen fouling, as the oxygen sensitivity at the bare 
electrode was essentially halved. The data points at 12 days are likely due to fluctuations of the 
control sensor from day-to-day. It is also of interest to note that, while the BSA study indicates 
that the sensor recovers near its original sensitivity, exposure to fibrinogen causes a permanent 
decrease in the sensitivity of the sensor. 
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3.4.4 Oxygen Sensitivity Changes with Exposure to Rat Brain Homogenate 
One would expect rat brain homogenate to have the most extensive fouling properties, as it 
contains all brain matter, including proteins such as BSA and fibrinogen, as well as glial cells 
and lipids. Indeed, with exposure to rat brain homogenate, Figure 3.7 shows that the PoPD 
coated electrode exhibits a 43% decrease in oxygen sensitivity (0.37±0.02 mA/ppm initial 




Figure 3.6 Oxygen sensitivity over time of PoPD-coated electrodes in control aCSF 




Figure 3.7 Oxygen sensitivity over time of PoPD-coated electrodes in control 10 mM PBS 
electrolyte (solid diamonds, n=4) and in test biofoulant 10 mM PBS/rat brain homogenate 
solution (open diamonds, n=4). 
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After 2 weeks of incubation, the PoPD-coated electrode exhibited a 38% decrease in sensitivity 
in biofouling solution (0.45±0.02 mA/ppm compared to the sensitivity obtained in control PBS 
0.73±0.02 mA/ppm at 14 days). The bare electrode (data not shown, n=1) exhibits a 28% initial 
decrease in oxygen sensitivity (control value of 0.79 mA/ppm to 0.57 mA/ppm after initial 
exposure); with exposure over 2 weeks the oxygen sensitivity for the bare electrode shows a 26% 
decrease in oxygen sensitivity compared to the control PBS value at 14 days (0.74 mA/ ppm to 
0.55 mA/ppm). Sensitivity changes for the PoPD-coated electrode in the presence of rat brain 
homogenate follows the same trend as that for the control electrolyte. This could indicate that the 
rat brain homogenate causes a fixed and permanent change to the PoPD layer, but the PoPD 
membrane itself changes with time (Fig. 3.2). Such variations in the PoPD layer are difficult to 
justify or quantify. In general, variations in sensitivity of the bare electrode (data not shown) are 
more extreme than those of the PoPD-coated. 
The oxygen sensitivity of the PoPD-coated sensor varies over time while being incubated 
in an electrolyte (Figs. 3.5, 3.6, 3.7). This indicates that there could be changes in PoPD 
permeability to oxygen over time. These variations are greater than the uncertainty in the 
experimental determinations of sensitivity. The inset of Fig. 3.1 indicates that the PoPD layer is 
dynamic, changing over time. The cause of this variability is not known, but these types of 
studies have not been done before. 
3.4.5 Simulation of in vivo Recalibration Practices 
 
For sensors calibrated in vitro then implanted, the matrix of the calibration solution 
should reflect that of the in vivo matrix. Keddie and Rohman noted that differences between the 
calibration solution and in vivo test environment most assuredly cause the probe to function 
“differently.”48 The main differences between in vivo and in vitro calibrations are: the mass 
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transport through a standard solution is different due to diffusion and convection, and there are 
numerous interferences from a complex sample matrix in vivo causing the limited operational 
stability of sensors in biological media.49-52 In addition, Kealy et. al expressed the need for 
caution when using in vitro calibrations to estimate in vivo concentrations because of key 
differences between in vitro solution and the in vivo matrix, namely “capacitance, current, 
diffusion, sensitivity, etc….”53 It is therefore unreasonable to calibrate the sensor in electrolyte 
and expect the sensitivity to be the same in vivo. Indeed, McHugh, et al., noted that “electrode 
responses in vivo may not be the same ex vivo,”54 and Singh, et al., stated that “postcalibration 
alone or averaging of pre- and postcalibration is likely to lead to over- or underestimation of 
analyte concentrations.”55 Despite this information, a number of researchers continue to utilize 
the practice of applying in vitro calibrations toward interpreting in vivo measurements.52-53, 56-57 
For current in vivo recalibration practices for various sensors the electrode is calibrated in 
electrolyte solution to obtain the sensitivity value, implanted, and then recalibrated upon removal 
of the probe, again in electrolyte.54-55, 58-60 If the sensitivity changes pre- and postcalibration then 
the sensitivity from the post-implantation is taken. Meyerhoff made the assertion that analyte 
values measured by the implanted blood-gas sensors decrease from corresponding in vitro 
measurements, but when removed and retested in vitro, “very accurate results are often 
obtained.”61 
We mimicked this process in vitro by calibrating the probe in an electrolyte solution, 
immediately after biofoulant exposure (t=0), 24 hours after biofoulant exposure, and again in the 
same, but fresh, electrolyte solution after a thorough rinsing. As is evident in Fig. 3.8(A), the 
oxygen sensitivity decreases significantly for both PoPD-coated and bare electrodes when 
exposed to BSA for 24 hours, followed by an increase when rinsed and recalibrated in 
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electrolyte. The PoPD-coated electrode returns to the original sensitivity within experimental 
error, whereas the bare electrode remains at a decreased value. The decreases in sensitivity range 
from 26–35% after immediate exposure to the biofoulants. Similar trends can be seen in Fig. 
3.8(B) with fibrinogen exposure, except that the sensitivity remains decreased even after 
rinsing. 
It is well known that sensor sensitivity drifts in vivo, but the in vitro data presented in 
Fig. 3.8(C) simulates what the drift in sensitivity might be. A major question is the magnitude of 
the error. By only considering the results obtained in the presence of the rat brain homogenate, 
the current procedure of using in vitro oxygen calibration pre- or post-implantation may report 
oxygen values that are off by as much as 30% (black or striped compared to gray or white). If rat 
brain homogenate is assumed to be similar to in vivo conditions, then the in vivo oxygen 
readings are in error by as much as 50% (black/striped to grey). The in vitro results suggest that 





Figure 3.8 Oxygen sensitivities from a mimic of in vivo recalibration methods with 





This study is the first to quantify the changes in sensitivity for oxygen sensors upon long-
term exposure to biofoulants using PoPD-coated gold electrodes. Data from in vivo sensors are 
affected by protein adsorption to the membrane, and therefore changes in sensitivity of the probe 
over time; potentially causing errors in the oxygen measurements. Different biofouling behavior 
was discussed as a proof of concept here. However, as most implantable oxygen sensors are 
Clark type microelectrodes with a larger surface to volume ratio, the kinetics and fouling are 
different from disk electrode discussed here. Therefore, the conclusion may not be directly 
transferable to in vivo sensors. In the Introduction section we referred to a study of brain oxygen 
levels that were not in agreement with each other;62-63 moreover, adjacent implanted sensors 
reported significantly different sensor responses. Sensitivity changes appear unique to each 
sensor, and also to each implantation. Since a membrane that resists all biofouling is currently 
unavailable, the solution to drifting sensitivity is to consider an in vivo calibration scheme after 
implantation. 
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generation-detection of oxygen 
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This chapter is reformatted from an article submitted to Sensors and Actuators: B Chemical 
entitled “In situ recalibration of a biofouled PoPD-coated oxygen sensor using generation-
detection of oxygen on a microelectrode array” with manuscript ID SNB-D-17-01158 (accepted 




Most chemical sensing development is based on newer platforms of technology. One of the 
practical limitations of sensors is their susceptibility to lose calibration when in use. Although 
some methods of in situ recalibration have been developed, sensors are normally recalibrated by 
extraction from the test environment and exposure to standards. In situ calibration has the 
advantage of avoiding extraction, which may cause tissue or sensor damage. It is well known 
that sensors lose calibration following in vivo implantation, and pre- and post-calibration 
methods have been used to compensate for the changes in sensitivity; we have recently reported 
and there is anecdotal evidence that the sensor sensitivity between the test environment and 
external calibration are not identical. Here we report the in situ recalibration of a biofouled 
oxygen sensor consisting of a polymer-coated microelectrode array. The sensitivity of a 
biofouled oxygen sensor decreases by 50% from the pre-calibrated sensitivity when incubated in 
fibrinogen solution. Our method of in situ recalibration predicts a new sensitivity for the 
biofouled oxygen sensor that is within 7% of the actual sensor sensitivity. This technique could 





Graphical abstract: In situ recalibration method by generation-detection of oxygen to 




Oxygen is of vital importance in biological systems and processes, ranging from 
environmental measurements to medical applications. Clinically, it has been shown that 
decreased oxygen levels in the brain are related to brain damage caused by trauma or ischemic 
stroke; patients with higher brain oxygen levels have a tendency to survive, while those with 
decreased brain oxygen do not. As stroke was the fifth leading cause of death in the U.S. in 2016, 
it is critically important to investigate methods to monitor the brain oxygen levels of these 
patients. There does not exist an absolute threshold value of brain oxygen level below which 
clinical intervention would be necessary because oxygen values vary significantly from patient to 
patient; these variations in one study were attributed to either differences in the probes or human 
error.1 These oxygen variations are likely a result of a change in the sensitivity of the sensor 
following implantation.  
In vivo sensors are typically calibrated pre- and post-implantation, and the sensor 
sensitivity while implanted is assumed to be the same as these calibrations. However, it is still 
unclear if in fact a post-calibration sensitivity is identical to that when the probe is implanted. 
There is some question whether using an in vitro calibration for determining in vivo 
measurements is accurate;2 indeed some reports estimate that in vivo glucose sensors can be in 
error by as much as 100%.3-4 In our previous work, we simulated an in vivo experiment which 
showed that the difference between in vitro and in vivo reported oxygen values could have a 
discrepancy of as much as 50%.5 This could have major implications for all in vivo sensors, 
including those that sense oxygen. Therefore, it is imperative that an alternative method of 
calibration is investigated. 
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There have been few reports of in situ recalibration for in vivo sensors.6-9 Typically, one-
point calibrations are used for glucose and dopamine sensors with high selectivity and no 
background current at zero substrate concentration, while two-point calibrations are for sensors 
in which the background current is significant at zero substrate concentration.10 Some 
researchers suggest that a one-point calibration could compensate for the immune response’s 
effect on sensor sensitivity,11 while others point out that multiple recalibrations may be necessary 
for long-term implanted sensors.12 Using carbon fiber microelectrodes, Roberts et al designed a 
method to predict a new sensitivity for measuring dopamine, ascorbic acid, hydrogen peroxide, 
and pH shifts during in vivo experiments by utilizing the background charging current as a 
means of predicting sensitivity; this method performs comparably to traditional ex vivo 
calibration methods without the need to remove the working electrode from the in vivo test 
environment.13  
All implanted devices are susceptible to the body’s immune response, including wound 
healing, protein adsorption, and eventual encapsulation.14-16 Protein adsorption to surfaces 
typically occurs quickly, and is usually followed by protein denaturation or conformational 
changes.17-19 Protein adsorption affects the calibration of the sensor by altering the permeability 
of the membrane, hence hindering the analyte’s ability to interact with the sensor surface.20 
Bovine serum albumin (BSA) and fibrinogen are typical proteins used as model biofoulants due 
to their high concentrations in blood plasma, and are both known to adsorb onto gold.21-24 BSA 
has a molecular weight of approximately 66 kDa while fibrinogen is approximately 340 kDa.25 
Additionally, fibrinogen has been shown to readily and strongly adsorb onto negatively-polarized 
gold surfaces, which is the case in this work.26 
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Many methods have been employed in an attempt to minimize the effect of biofouling.27 
Liu et al. applied a BSA pretreatment (called “blocking,” as a method to reduce nonspecific 
adsorption) to a carbon fiber electrode for in vivo dopamine sensing which showed similar 
results for pre- and post-calibration.28 Ren et al. employed a nitric oxide generation/release 
scheme that actively inhibited biofouling for an amperometric oxygen sensing catheter;29 a 
similar method has been employed for use with an in vivo glucose sensor.30 Yang et al. noted 
that by coating a zwitterionic poly(carboxybetaine) hydrogel onto a glucose sensor, blood-
materials interactions were minimized and the life of the sensor was extended.31 Poly-o-
phenylenediamine (PoPD) has been used as a protective coating for many types of sensors, 
including glucose,32-36 hydrogen peroxide,37-42 oxygen,43-45 and others.46-51 While there has been 
extensive research of coatings used to minimize biofouling, some researchers have concluded 
that a completely anti-fouling coating is unlikely to ever be realized.52  
In situ oxygen generation has been developed but not used for in situ recalibration of 
oxygen sensors. Sherman et al. were able to electrochemically produce and quantify oxygen with 
their dual working electrode collector-generator cell using fluorine doped tin oxide electrodes.53 
Sun et al. immobilized two different enzymes onto GC/AuNP electrodes to take advantage of the 
enzymes’ reactions that generate oxygen as a coreactant, which then acted as a signal amplifier 
in their electrochemiluminescent detection of carcinoembryonic antigen.54 Yang et al. developed 
a porous cobalt catalyst that can be used for both hydrogen and oxygen generation depending on 
the potential applied, which could be of great importance for use in renewable energy devices.55 
Xu et al. designed a nanofluidic device with an embedded microband electrode that can generate 
oxygen; generated oxygen is monitored and quantified using fluorescence and pH relationships.56 
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While these studies have successfully generated oxygen in situ, we present the first study of an in 
situ recalibrated oxygen sensor using microelectrode arrays. 
 
4.3 Materials and Methods 
4.3.1 In Situ Recalibration Method 
 
In a previous study, an in situ recalibration method was described for an oxygen sensor 
using macroelectrodes;57 this work applies that same in situ recalibration method to 
microelectrode arrays. Microelectrode arrays offer the advantage of individually addressable 
electrodes, which allows for precise electrodeposition and the ability to utilize distinct electrodes 
for different purposes; for example, one can apply a constant potential at one electrode to 
generate oxygen, while obtaining cyclic voltammetry data on a neighboring electrode to detect 
the increase in oxygen concentration. Microelectrodes are also a more viable option when 
studying possible in vivo applications because their smaller size is likely to cause less tissue 
trauma upon implantation.  
Electrochemical oxygen sensors function by measuring the steady-state diffusion limiting 
current, iDL, which is proportional to the concentration of oxygen in the test environment, Cs, and 
the sensor sensitivity, S: 
𝑖𝐷𝐿 = 𝑆𝐶𝑆      (1) 
 The sensitivity of the sensor is determined by two factors: permeability of the membrane, Pm, 




      (2) 
Biofouling changes the properties of the membrane, causing a change in sensor 
sensitivity from an initial value of S1 to an unknown value of S2. Currently, the only way to 
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determine S2 is to remove the sensor from the test environment and perform a calibration. 
However, by introducing a second oxygen-generating electrode (GE), external to the membrane, 
oxygen can be generated without the need to remove the probe. To recalibrate the sensor and 
find S2, the GE is poised at a potential such that water is oxidized to oxygen. This will cause a 
local change in the concentration profile which causes an increase in the steady-state 
concentration of oxygen at the surface of the membrane CS at the surface of the oxygen 
sensor’s membrane, provided it is close enough to the GE: 
𝑖𝐺𝐸 = (∆𝐶𝑆)      (3) 
where iGE is the steady-state current value at the GE, and  is a proportionality constant specific 
to the geometry of the electrode.57 The local change in concentration of oxygen will also cause a 
change in diffusion limiting current, iDL, as shown in Equation (4): 
Δ𝑖𝐷𝐿 = 𝑆(∆𝐶𝑆)     (4) 
To determine , an oxygen calibration curve is constructed, the slope being S1 for the 
electrode; then, oxygen generation-detection is performed to determine iGE and the change in 
detector limiting current, iDL; then, knowing iDL and S1, CS can be found using Equation (4); 
finally, one can solve for  by using Equation (3). An example illustrating this method is shown 
in Fig. 4.1. Once  is known, if a sensitivity change then occurs, such as a biofouling event, the 






      (5) 
4.3.2 Reagents 
 
O-phenylenediamine (oPD) monomer (Sigma, St. Louis, MO), bovine albumin 
(Amresco, Solon, OH), bovine fibrinogen (Alfa Aesar, Ward Hill, MA), phosphate buffered 
saline tablets (PBS) (EMD Millipore, Billerica, MA), K2PtCl4 salt (Sigma-Aldrich, St. Louis, 
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MO) were obtained. Solutions of oPD monomer (300 mM) were prepared in 10 mM PBS. 
Unless otherwise stated, experiments were performed in PBS solution, pH 7.4 (140 mM NaCl, 
10 mM phosphate buffer, 3 mM KCl). A CH Instruments 1030A potentiostat, Ag/AgCl (in sat’d 
KCl) reference electrode, and platinum flag counter electrode were used in all experiments. 
4.3.3 Electrode Preparation 
 
Microelectrode arrays (MEAs) were constructed on silicon wafer substrate via 
photolithography. Microelectrodes used in the study consisted of an array of sixteen 
interdigitated microbands on a 1 inch x 1 inch silicon substrate. Each of the bands were 2 mm 
long, 25 µm wide and the gap between two adjacent bands was 25 µm. The microband arrays 
were constructed by applying UV photolithography technique on the metallized layer of 10 nm 
titanium/500 nm gold on the silicon wafer. The areas except the exposed bands on the substrate 
were protected with an insulating layer of benzocyclobutane. The finished MEA chip was 
cleaned via oxygen plasma and stored in deionized water. Polymerization solutions of 300 mM 
oPD monomer were prepared by dissolving in 10 mM PBS and sonicating for 30 minutes; PoPD-
coated gold microband electrodes were produced by applying a constant potential of +0.9 V (vs 
Ag/AgCl in sat’d KCl reference) for 30 minutes.58 Generator electrodes (GE) were prepared by 
electrodepositing platinum on top of the gold microband electrode: 3 successive depositions in 
20 mM K2PtCl4 in 1 M HClO4 by applying a constant potential of -0.1 V vs Ag/AgCl in sat’d 
KCl reference for a pulse width of 5 seconds each.59 
4.3.4 Oxygen Calibration Curves 
 
The test solution (either control electrolyte PBS or PBS/biofoulant solution) was purged 
of oxygen by bubbling nitrogen and allowing ambient oxygen to re-dissolve. The dissolved 
oxygen concentration was measured using a YSI Pro20 oxygen meter (Yellow Springs, OH). 
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Cyclic voltammograms (CVs) of increasing dissolved oxygen concentration were obtained at 
PoPD-coated microelectrodes by sweeping the potential from 0 V to -1.0 V vs Ag/AgCl in sat’d 
KCl reference electrode. Calibration curves were then constructed by plotting the resulting 
current value at -0.6 V vs Ag/AgCl in sat’d KCl reference electrode versus the dissolved oxygen 
concentration; sensor sensitivity to oxygen is taken as the slope of this line. 
4.3.5 Determination of  and Recalibration of Sensitivity 
 
A cyclic voltammogram (CV) was taken on the DE from 0 to -1.0 V vs Ag/AgCl in sat’d 
KCl reference electrode to reduce the ambient oxygen. Then, the GE was poised at a constant 
potential of +1.4 V vs Ag/AgCl in sat’d KCl reference electrode to generate oxygen from water; 
simultaneously, another CV was taken on the DE from 0 to -1.0 V vs Ag/AgCl in sat’d KCl 
reference electrode to reduce and detect the generated and endogenous oxygen. This is illustrated 
in Fig. 4.1. The change in current at the DE, iDL, was obtained by taking the difference in 
current response at -0.6 V from the resulting CVs and the current at the GE, iGE. Values were 
then used along with the sensitivity, S1, from Section 4.2.4, to calculate the  term. Once  was 
known, another generation-detection experiment was performed while the MEA was incubated 
in test solution containing biofoulant, and a new sensitivity, S2, was predicted for the biofouled 
electrode. 
4.4 Results and Discussion 
4.4.1 Electrodeposition of Platinum on a MEA 
 
An alternative GE material to gold was necessary due to the high positive potential 
needed to generate O2. An over coating of platinum was selected because it offers the advantage 
electrocatalytic activity. Investigations determining an adequate method to deposit platinum onto 
the gold microband electrode commenced. After many trials of various procedures, the method 
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described in Section 4.2.3 was determined to produce the most robust and repeatable platinum 
deposition that generates sufficient amounts of O2, without dissolution of the GE. A diagram of 




Figure 4.1 Generation-detection of oxygen data example for in situ recalibration. CVs are 
obtained on the DE both with the GE “on” (blue circles) and “off” (orange squares), and 
the GE while “on” (red triangles). iDE is the difference between current values of 
“Generator on” and “Generator off” for the DE, and iGE is the current at the GE of 
“Generator on,” both taken at -0.6 V vs Ag/AgCl in sat’d KCl reference electrode. The left 
axis corresponds to the DE for both “Generator on” and “Generator off” CVs; the right 




Figure 4.2 Diagram of the MEA chip showing dimension schematics. Zoomed in section 
shows the dimensions of the microbands, as well as the Pt deposition on Au. 
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4.4.2 Oxygen Sensor Response with Exposure to BSA 
 
BSA is commonly used as a model foulant in biofouling studies. We showed in a 
previous study that BSA initially fouls substantially, followed by protein desorption from the 
sensor surface as is evident by sensor sensitivity returning to a similar pre-fouled value.5 This 
work began by intentionally fouling the PoPD-coated microband electrodes with 6 g/L BSA 
solution and monitoring the oxygen sensitivity over time. Unlike our previous work which 
exhibited dramatic decrease in sensitivity initially, Fig. 4.3 indicates that BSA did not adsorb to 
the PoPD-coated oxygen sensor, as the sensor sensitivity to oxygen did not appreciably change 
over time. It can be concluded therefore that BSA is not a primary biofoulant for gold microband 
electrodes as it was for the gold macrodisk electrode counterparts. The reason for this is 
unknown ostensibly; the only difference between the two are the edge effects that are more 
pronounced in microelectrodes. 
4.4.3 Oxygen Sensor Response with Exposure to Fibrinogen 
 
Fibrinogen has been shown in our previous work to be a substantial fouling protein.5 
Oxygen calibration curves were obtained on the PoPD-coated microelectrode in control 
electrolyte (10 mM PBS), immediately following incubation in 3 g/L fibrinogen solution, and 
after one day of incubation in fibrinogen solution. These calibration curves are presented in Fig. 
4.4. In control electrolyte, the PoPD-coated microelectrode exhibited an oxygen sensitivity of 
33.0 nA/ppm. Upon immediate incubation in fibrinogen solution, the oxygen sensitivity 
decreased to a value of 24.7 nA/ppm, and after one day of incubation it further declined to a 
value of 22.0 nA/ppm. This follows the trend expected based on our previous study, which 




Figure 4.3 Oxygen calibration curves for a PoPD-coated electrode (n=1) in control 
electrolyte (10 mM PBS, blue circles), and while incubated in BSA solution immediately 
following incubation (orange triangles) and after 12 hours of incubation (gray squares); O2 
current value taken at -0.6 V vs Ag/AgCl in sat’d KCl reference. 
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Figure 4.4 Oxygen calibration curves for a PoPD-coated electrode (n=1) in control 
electrolyte (10 mM PBS, blue circles), and while incubated in fibrinogen solution 
immediately following incubation (orange triangles) and after 1 day of incubation (gray 
squares). The predicted sensitivity after 1 day of fibrinogen incubation is also plotted 
(green dashed line); O2 current value taken at -0.6 V vs Ag/AgCl in sat’d KCl reference. 
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4.4.4 In Situ Recalibration 
 
Oxygen generation-detection experiments were then performed on the biofouled PoPD-
coated microelectrode as described in Section 4.2.5. Using the  value calculated from Equation 
(3) for the bare gold microelectrode in control electrolyte, a new oxygen sensitivity was 
predicted for the biofouled electrode after one day of incubation (Table 4.1). Since all electrodes 
behave differently, each PoPD-coated electrode was treated individually to prove the efficacy of 
the method. Table 4.1 describes the experimental values for the three individual electrodes, 
including the distinct  values, and sensitivities obtained in control electrolyte (10 mM PBS) and 
3 g/L fibrinogen solution both immediately following incubation and after 1 day of incubation. 
In addition, using data obtained during Generation-Detection of Oxygen experiments (Section 
2.5), predicted sensitivities were calculated for each of the biofouled electrodes after 1 day of 
incubation in fibrinogen solution. The predicted sensitivity values for all 3 electrodes are in 
agreement with the true sensitivity values (fibrinogen t=1 day) within an error of 7%. In addition, 
the Pt/Au GE is able to generate O2, even when incubated in the same biofouling solution; this 
shows that the ability for the GE to generate O2 is unaffected by biofouling. 
It has been stated previously that even a slight change in calibrated sensitivity of an 
oxygen sensor can cause a significant discrepancy in measured oxygen values. For example, as 
can be seen in Fig. 4.4, if the sensor sensitivity obtained in control electrolyte (33.0 nA/ppm) is 
used to measure dissolved oxygen when incubated in fibrinogen solution, a current response of 
150 nA leads to a reported oxygen value of approximately 4.51 ppm; using the actual sensor 
sensitivity (22.0 nA/ppm), the same current response of 150 nA, the reported oxygen value 
would be approximately 6.50 ppm. While the percent error between sensor sensitivity obtained 
in control electrolyte and biofoulant solution is 50%, this induces a total error in reported oxygen 
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values of 31%. If the recalibrated sensitivity (23.5 nA/ppm) is used, a current response of 150 nA 
would result in a reported oxygen value of 6.38 ppm O2 (an error of 1.85%). Most researchers 
would use the sensitivity value for control electrolyte, assuming that it remains the same when 
incubated in the test environment; our results show that the sensitivity does change significantly 
when incubated in a protein solution, which would lead to inaccurate reported oxygen values. 
However, using our method of in situ recalibration, the biofouled sensor sensitivity is accounted 
for, leading to more accurate reported oxygen values. This could have significant implications 
for in vivo sensors used in clinical settings. 
 
  



















1 173 41.4 32.2 34.0 31.9 6.01 
2 198 33.6 26.4 28.0 29.7 6.25 
3 141 33.0 24.7 22.0 23.5 7.04 




This work shows the efficacy of an in situ recalibration method of a biofouled oxygen 
sensor using polymer-coated microelectrode arrays. Each sensor behaves differently and has its 
own individual sensitivity and therefore should be treated independently.13 Using this method of 
in situ recalibration, biofouled electrodes were recalibrated to within 7% error of the actual 
calibration when incubated in fibrinogen solution. However, this method has its limitations and 
cannot account for excessive fouling (6 g/L concentration fibrinogen, nearly double the normal 
endogenous concentration in blood), which caused a complete suppression of oxygen sensitivity 
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(data not shown). There are a few possibilities for why this method is unable to achieve 0% 
error. It is possible that the electrodes become extremely fouled, leading to the detector electrode 
being unable to detect the change in O2 concentration. This could be due to O2 either not being 
generated at the GE; or, if O2 is generated at the GE, the O2 not being able to diffuse and be 
detected by the DE. The data suggest that it is likely not the former, as generator currents remain 
the same order of magnitude as the control, before fouling. It is feasible that the O2 generated at 
the GE cannot diffuse through the biofilm either on the GE, the DE, the space between the GE 
and DE, or some combination of all three. A method to investigate this is by using scanning 
electrochemical microscopy, SECM. This technique would allow investigation as to which 
microenvironment is causing the decreased change in DE current. 
As all generate-detect experiments were done in ambient O2, the biofilm layer could 
already be saturated with O2, and therefore generating additional O2 will not have an impact on 
the DE current. A way to test this would be to purge the biofilm layer of O2 by keeping the DE 
on closed circuit at -0.6 V, while the bulk solution is also purged with N2; if the biofilm is O2 
saturated then over time, the DE current should decrease to a constant value as all O2 is reduced 
in the layer.  
Another possibility is that the generated O2 is able to diffuse through the unsaturated 
biofilm, but diffusion is much slower, too slow in fact to see the apparent change in DE current 
on our experimental time scale. A method to investigate this possibility would be to use 
electrochemical time of flight, ETOF. Using ETOF, the diffusion coefficient of O2 through the 
biofilm could be determined. This would give information about how quickly generated O2 could 
diffuse through the biofilm and be detected at the DE. Chronoamperometry could also be used 
instead of cyclic voltammetry, in which the current at steady-state could be used in calculating xi 
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and predicting a new sensitivity for the oxygen sensor, since chronoamperometry would not have 
the added disadvantage of being dependent on the duration of the experiment. 
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5. Conclusions and Future Work 
5.1 Conclusions 
 The investigations described in this dissertation contribute to the field of in vivo oxygen 
sensors. Until these works, in vivo sensors operated under the assumption that in vitro sensor 
calibration remains valid when implanted in vivo. Studies described here demonstrate not only 
that this assumption is not valid, but also provide quantification of the change in sensor 
sensitivity when incubated under ex vivo conditions. Furthermore, studies described here 
propose a method for in situ recalibration of a biofouled sensor without necessitating removal of 
the sensor from the test environment. These studies have implications not only for oxygen 
sensors, but also for a wide variety of implantable electrochemical sensors. 
 First, polyeugenol (PE), which had been shown in previous work to be a promising 
polymer membrane for in vivo sensors, was electropolymerized onto individually addressable 
microelectrodes on a microelectrode array. The PE membrane was investigated for membrane 
coating uniformity and durability via potassium ferricyanide as a probe molecule. The PE 
membrane was proven to be permeable to oxygen through a calibration study, as well as 
uniformly covering the microelectrode surface through a probe molecule study. However, PE 
was shown to not be stable after 24 hours, as evidenced by the appearance of a ferricyanide 
electrochemical signal at this time point. Therefore, although permeable to oxygen, PE was not 
used for the duration of this work due to its instability over time. 
 Second, poly-o-phenylenediamine (PoPD) was investigated for use as a protective 
membrane. PoPD was shown to be permeable to oxygen, uniformly coated on the 2 mm gold 
macroelectrode, and stable over time. The PoPD membrane exhibited stability over time as 
shown through the probe molecule study with potassium ferricyanide. In addition, the PoPD-
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coated electrode showed oxygen permeability and sensitivity over time in control electrolyte 
solution. This study also used a PoPD-coated and bare gold macroelectrodes to study the effects 
of biofouling when incubated in various foulant solutions over a period of 13-19 days. PoPD-
coated electrodes exhibited more consistent sensitivity values when incubated in biofouling 
solutions than did bare electrodes. In addition, a study simulating an in vivo experiment calls into 
question current methods of calibrating in vivo sensors, as these data show significant changes of 
oxygen sensitivity when incubated in foulant solutions. This is the first study to my knowledge 
that quantifies the changes in sensitivity of an oxygen sensor due to biofouling. However, this 
work may not be directly applicable to in vivo sensors, as the reaction kinetics and fouling would 
be different between ex vivo and in vivo test environments. This study was a crucial experiment 
to prove the viability of PoPD as a protective polymer membrane coating for an in vivo oxygen 
sensor, as well as the first to quantify sensitivity changes due to biofouling of an oxygen sensor. 
 Third, PoPD was electropolymerized onto an individually addressable gold microband 
electrode on a microelectrode array. Microelectrodes are on a more feasible scale to apply as an 
in vivo sensor, as they would induce less tissue damage upon implantation than would the sensor 
using a macroelectrode in the previous study. The effects of biofouling were studied on a PoPD-
coated microelectrode. In addition, a new method of in situ recalibration of a biofouled PoPD-
coated microelectrode was proposed and its efficacy studied. The PoPD-coated electrode 
exhibited no appreciable change in oxygen sensivitiy when incubated in bovine serum albumin 
(BSA) solution; however, when incubated in fibrinogen solution, the PoPD-coated electrode 
exhibited a 16-33% change in oxygen sensitivity. The in situ recalibration method was able to 
effectively predict a new oxygen sensitivity for the fibrinogen-fouled PoPD-coated electrode to 
within 7% error of the experimental oxygen sensitivity value. This study serves as a proof-of-
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concept for the in situ recalibration method; nevertheless, this is a profound result, and could 
have significant implications for a variety of implantable electrochemical sensors.  
5.2 Future Work 
 The work described in this dissertation serves as fundamental research and application of 
polymer-coated gold electrode used for oxygen sensing. The future of this project requires 
fabrication of an in vivo probe. The probe, which was first designed by the Paul/Fritsch groups 
and Dr. Mengjia Hu, will be made out of SU8, an epoxy-based material that can be produced on 
the microscale via standard photolithography methods and provide tensile strength for clinical 
applications.1-4 The design of the probe, shown in Fig. 5.1, has an implantable tip with 
dimensions of 7 mm long, 100 m wide, 100 m thick; the electrode array on the probe tip 
contains 9 active band electrodes of length 100 m and width 4 m, with 4 m gap between 
electrodes. The microbands connect to an edge connector at the other end of the probe, making 
electrical connections to electrode leads of a potentiostat. This probe could be implanted in rat 
brain, and real-time oxygen levels can be monitored. Through use of this probe, the in situ 
recalibration technique described in this dissertation could recalibrate a biofouled in vivo oxygen 
sensor. In this way, the implanted probe would not need to be explanted and recalibrated in an 
external environment, improving the field of in vivo sensor calibration and function. In addition 
to oxygen, the in situ recalibration method described in this work could be applicable to a variety 
of other in vivo electrochemical sensors.  
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Figure 5.1 Probe design of microelectrode array; original design of Dr. Mengjia Hu and 
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